Matches in Wikidata for { <http://www.wikidata.org/entity/Q85006028> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q85006028 description "article scientifique publié en 2012" @default.
- Q85006028 description "artículu científicu espublizáu en setiembre de 2012" @default.
- Q85006028 description "im September 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q85006028 description "scientific article published on 01 September 2012" @default.
- Q85006028 description "wetenschappelijk artikel" @default.
- Q85006028 description "наукова стаття, опублікована у вересні 2012" @default.
- Q85006028 name "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 name "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 type Item @default.
- Q85006028 label "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 label "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 prefLabel "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 prefLabel "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 P1433 Q85006028-CD1640A8-FAA5-47CB-92F1-ED6AA48D98E8 @default.
- Q85006028 P1476 Q85006028-7FA29E07-43A0-4F5E-90C9-9D6ED379CDBA @default.
- Q85006028 P2093 Q85006028-0600BE4E-933A-470C-B67E-53B16B0FDE42 @default.
- Q85006028 P2093 Q85006028-0966DBFA-30A3-4D83-A73C-1D6660CF9B66 @default.
- Q85006028 P2093 Q85006028-1678ED7C-E635-4BD2-8FDB-99912658878D @default.
- Q85006028 P2093 Q85006028-1869DF88-997A-4BFE-9991-02B52411C430 @default.
- Q85006028 P2093 Q85006028-CBD27D08-7E9D-4F95-90E7-93B77ACF8E90 @default.
- Q85006028 P304 Q85006028-12EDFF93-81F7-44FD-A5D3-510DDDADF71A @default.
- Q85006028 P31 Q85006028-D553AFF5-0DB8-4CB2-9A73-075C78EA1F30 @default.
- Q85006028 P356 Q85006028-80608EE1-0458-46E4-ADBB-BD5F8E51E430 @default.
- Q85006028 P433 Q85006028-31666DA1-9C6D-4414-8F51-E1AEEFD8E1C0 @default.
- Q85006028 P478 Q85006028-178BEED4-D06D-4423-BF3F-1AB9A909FB26 @default.
- Q85006028 P50 Q85006028-C24D2AA1-EF39-4176-B3CD-AC43B0536D21 @default.
- Q85006028 P577 Q85006028-BC93D3F2-4933-45B2-99B7-468DCA6C8FB9 @default.
- Q85006028 P698 Q85006028-D9E62A0A-3A34-4ED4-85F7-D31AE4016851 @default.
- Q85006028 P356 J.JASH.2012.07.003 @default.
- Q85006028 P698 22995802 @default.
- Q85006028 P1433 Q15816756 @default.
- Q85006028 P1476 "Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy" @default.
- Q85006028 P2093 "Andrew S Bomback" @default.
- Q85006028 P2093 "Gerald B Appel" @default.
- Q85006028 P2093 "Jai Radhakrishnan" @default.
- Q85006028 P2093 "Philip J Klemmer" @default.
- Q85006028 P2093 "Yelena Rekhtman" @default.
- Q85006028 P304 "338-345" @default.
- Q85006028 P31 Q13442814 @default.
- Q85006028 P356 "10.1016/J.JASH.2012.07.003" @default.
- Q85006028 P433 "5" @default.
- Q85006028 P478 "6" @default.
- Q85006028 P50 Q56855760 @default.
- Q85006028 P577 "2012-09-01T00:00:00Z" @default.
- Q85006028 P698 "22995802" @default.